THCT (THC Therapeutics) EV-to-EBIT : -1.55 (As of Jul. 23, 2025)

THC Therapeutics EV-to-EBIT Chart

THC Therapeutics Annual Data
	Trend	Jul14	Jul15	Jul16	Jul17	Jul18	Jul19	Jul20	Jul21	Jul22	Jul23
EV-to-EBIT		Get a 7-Day Free Trial					-1.64	-1.31	-2.70	-1.19	-2.72

THC Therapeutics Quarterly Data
	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
EV-to-EBIT	Get a 7-Day Free Trial															17.84	-2.72	0.42	-1.72	-1.77

Competitive Comparison of THC Therapeutics's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, THC Therapeutics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

THC Therapeutics's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, THC Therapeutics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where THC Therapeutics's EV-to-EBIT falls into.

THC Therapeutics EV-to-EBIT Calculation

THC Therapeutics's EV-to-EBIT for today is calculated as:

THC Therapeutics's current Enterprise Value is $0.75 Mil.
THC Therapeutics's EBIT for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Therapeutics  (OTCPK:THCT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

THC Therapeutics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Apr. 2024 is calculated as:

THC Therapeutics's Enterprise Value for the quarter that ended in Apr. 2024 was $0.86 Mil.
THC Therapeutics's EBIT for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Therapeutics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of THC Therapeutics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

THC Therapeutics Business Description